Brief: Ocugen Signs Letter Of Intent To Acquire Vaccine Manufacturing, R&D Hub In Ontario, Canada

Liminal BioSciences

27/01/2022 14:39

Jan 27 (Reuters) - Ocugen Inc  OCGN.O :
    * OCUGEN, INC. SIGNS LETTER OF INTENT TO ACQUIRE VACCINE
MANUFACTURING, RESEARCH AND DEVELOPMENT HUB IN ONTARIO, CANADA
    * OCUGEN - SIGNED A NON-BINDING LOI WITH LIMINAL BIOSCIENCES
FOR
ACQUISITION OF THEIR MANUFACTURING SITE IN BELLEVILLE, ONTARIO 
FOR UNDISCLOSED AMOUNT
    * NEW FACILITY INCLUDES POTENTIAL FOR MANUFACTURING FOR
BREAKTHROUGH GENE THERAPIES AND SERVE AS RESEARCH AND
DEVELOPMENT HUB

Source text for Eikon:  ID:nGNX5yHzBn 
Further company coverage:  OCGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))